Lexaria Bioscience (LEXX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Lexaria Bioscience has initiated a groundbreaking study to explore the biodistribution of its DehydraTECH-semaglutide formulation using fluorescent imaging in rodents. This research aims to determine whether Lexaria’s technology enhances the effectiveness and safety profile of semaglutide compared to standard oral formulations.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.
